Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Osimertinib

Osimertinib resistance and transformation from adenocarcinoma to small cell lung cancer: case report

    • 4 Accesses

    This is a preview of subscription content, log in to check access.

    Reference

    1. Chen S, et al. Third-generation TKI resistance due to sclc transformation: A case report and brief review. OncoTargets and Therapy 12: 11305-11311, 19 Dec 2019. Available from: URL: http://doi.org/10.2147/OTT.S228301

    Download references

    Rights and permissions

    Reprints and Permissions

    About this article

    Verify currency and authenticity via CrossMark

    Cite this article

    Osimertinib. Reactions Weekly 1791, 203 (2020). https://doi.org/10.1007/s40278-020-75048-6

    Download citation